Page last updated: 2024-12-08
streptothricin f
Description
streptothricin F: streptothricin group of antibiotics; see also racemomycins: 11006-72-7, streptothricin E for racemomycin C: 3776-38-3, yazumycin: 11051-45-9; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
streptothricin F : A streptothricin in which the peptide side-chain consists of a single unit of beta-lysine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
streptothricin F(3+) : A primary aliphatic ammonium ion which is obtained from streptothricin F by protonation of the guanidino and amino groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
Synonyms (14)
| Synonym |
|---|
| antibiotic s 15-1a(3+) |
| streptothricin vi tri-cation |
| yazumycin a(3+) |
| streptothricin f(3+) |
| streptothricin f tri-cation |
| racemomycin a(3+) |
| streptothricin vi(3+) |
| CHEBI:60822 |
| racemomycin a tri-cation |
| antibiotic s 15-1a tri-cation |
| (4s)-6-{[(2r,3r,4s,5r,6r)-5-(carbamoyloxy)-4-hydroxy-6-(hydroxymethyl)-2-{[(2e,3as,7r,7as)-7-hydroxy-4-oxooctahydro-2h-imidazo[4,5-c]pyridin-2-ylidene]ammonio}tetrahydro-2h-pyran-3-yl]amino}-6-oxohexane-1,4-diaminium |
| yazumycin a tri-cation |
| streptothricin f |
| Q27128697 |
Roles (1)
| Role | Description |
|---|
| antimicrobial agent | A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (2)
| Class | Description |
|---|
| guanidinium ion | R = C or H. The iminium ion resulting from the protonation of one of the imine nitrogens of guanidine or its derivatives. |
| primary aliphatic ammonium ion | The conjugate acid of a primary aliphatic amine. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (9)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |